This article was originally published on Natural News. You can read the original article HERE
World’s first peer-reviewed study on anticancer benefits of ivermectin, mebendazole and fenbendazole published in reputable journal
Drs. William Makis, Paul Marik, Ilyes Baghli and numerous other scientists and doctors from the The Frontline COVID-19 Critical Care Alliance (FLCCC) put together a phenomenal research study that has the potential to save the lives of many cancer patients who would otherwise undergo conventional treatments like chemotherapy and radiation that threaten to kill them, not heal them.
In a tweet about the new study, Dr. Makis thanked lead authors Baghli and Pierrick Martinez for what he described as "incredible inspired work" on these powerful repurposed drugs that came to the forefront of alternative medicine as a result of the Wuhan coronavirus (COVID-19) "pandemic."
"I hope that this peer-reviewed paper lays the groundwork for a brand new future for Cancer Treatment," Dr. Makis wrote in the tweet.
"Many of you know that I have been helping thousands of Cancer patients with high dose Ivermectin, Mebendazole, and Fenbendazole. We are already starting to see incredible successes with these repurposed drugs."
(Related: Be sure to also check out this report we published last year about the synergistic effects of pairing ivermectin with fenbendazole as a prophylactic and treatment regimen for cancer.)
mRNA COVID injections "collapsed" mainstream oncology, Dr. Makis says
After the rollout of Operation Warp Speed, turbo cancers started spiking to the point that the medical system, and particularly the field of oncology, was no longer able to handle the heavy volume of sick and dying cancer patients who developed the disease after getting jabbed for COVID.
Dr. Makis describes this phenomenon as the "collapse" of mainstream oncology, which he squarely blames on the rollout of "contaminated COVID-19 mRNA Vaccines."
"Most Oncologists abandoned their Hippocratic Oath, gave contaminated mRNA Vaccines to all their cancer patients and took the mRNA jabs themselves," Dr. Makis writes.
"Some Oncologists have now developed mRNA Induced Cardiac arrests, blood clots and Turbo Cancer. Others have already died suddenly. These Oncologists buried their heads in the sand and abandoned everything that it takes to be a good, competent doctor."
To help remedy this while stopping the spread of turbo cancer, individuals are advised to stop taking any and all COVID "vaccines." If a person already has cancer, the new paper from Makis et al. recommends the following:
Ivermectin
Low-grade cancers:
Dose of 0.5mg / kg body weight 3x per week
Intermediate-grade cancers:
Dose of 1mg / kg body weight 3x per week
High-grade cancers:
Dose from 1mg / kg body weight to 2mg / kg body weight daily
Mebendazole / Fenbendazole
Low-grade cancers:
Dose 200mg / day of mebendazole
Intermediate-grade cancers:
Dose 400mg / day of mebendazole
High-grade cancers:
Dose 1,500mg / day of mebendazole
Dose 1,000mg / three times weekly of fenbendazole
On X / Twitter, someone named "GinaH" (@ginahens1) told a story about how she paid cash for these drugs and took them alongside chemotherapy, immunotherapy, surgery and radiation because her diagnosis was terminal – "but it worked," she says.
"Does that mean cancer is a parasitic disease?" asked another, noting that ivermectin, mebendazole and fenbendazole are all used to treat parasites.
"Finally, a breakthrough into the main," wrote another, celebrating the fact that a study like this was finally published in a reputable, peer-reviewed journal. "Wait til they find out HCQ (hydroxychloroquine) destroys lung carcinomas."
"Unbelievable that these drugs work and could have saved so many lives, yet people were deplatformed for saying this!" expressed another.
You will find more information about keeping your body cancer-free at CancerSolutions.news.
Sources for this article include:
This article was originally published by Natural News. We only curate news from sources that align with the core values of our intended conservative audience. If you like the news you read here we encourage you to utilize the original sources for even more great news and opinions you can trust!
Comments